Latest Articles

Publication Date
Married at First Sight UK's Lacey got candid about her health - MSN

Married at First Sight UK's Lacey got candid about her health MSN

Published: Dec. 18, 2024, 1:24 p.m.
Hampshire fire service faces £6m deficit in 2025 - Bordon Herald

Hampshire fire service faces £6m deficit in 2025 Bordon Herald

Published: Dec. 18, 2024, 11:54 a.m.
Hampshire fire service faces £6m deficit in 2025 - Liphook Herald

Hampshire fire service faces £6m deficit in 2025 Liphook Herald

Published: Dec. 18, 2024, 11:53 a.m.
Hampshire fire service faces £6m deficit in 2025 - Alton Herald

Hampshire fire service faces £6m deficit in 2025 Alton Herald

Published: Dec. 18, 2024, 11:52 a.m.
Pelvic pain and what to do about it - Sunbury Macedon Ranges Star Weekly

Pelvic pain and what to do about it Sunbury Macedon Ranges Star Weekly

Published: Dec. 13, 2024, 10:59 a.m.
Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial BioSpace

Published: Dec. 12, 2024, 11:25 p.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Laura Barlow: Face-to-face GP appointments petition hits 100,000 - BBC.com

Laura Barlow: Face-to-face GP appointments petition hits 100,000 BBC.com

Published: Dec. 9, 2024, 8 p.m.
Laura Barlow: Face-to-face GP appointments petition hits 100,000 - BBC

Laura Barlow: Face-to-face GP appointments petition hits 100,000 BBC

Published: Dec. 9, 2024, 3:54 p.m.
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer BioSpace

Published: Dec. 6, 2024, 8:22 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!